| 000 | 01447 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513113557.0 | ||
| 264 | 0 | _c19970417 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0038-4348 | ||
| 024 | 7 |
_a10.1097/00007611-199703000-00022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleming, D R | |
| 245 | 0 | 0 |
_aParkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma. _h[electronic resource] |
| 260 |
_bSouthern medical journal _cMar 1997 |
||
| 300 |
_a364-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aHemofiltration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoglobulin kappa-Chains |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aRenal Insufficiency _xcomplications |
| 700 | 1 | _aMangino, P B | |
| 773 | 0 |
_tSouthern medical journal _gvol. 90 _gno. 3 _gp. 364-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007611-199703000-00022 _zAvailable from publisher's website |
| 999 |
_c9062600 _d9062600 |
||